Scientists have unveiled a groundbreaking treatment aimed at reducing harmful cholesterol levels.
Initial findings indicate major reductions in cholesterol without the usual side effects associated with conventional medications.
Harmful cholesterol, known as low-density lipoprotein (LDL), is a waxy substance responsible for transporting cholesterol to cells. Excessive amounts can accumulate in the walls of arteries, impeding blood flow and substantially heightening the risk of heart attacks and strokes.
A novel DNA-based treatment has been developed that inhibits a crucial protein responsible for maintaining elevated levels of bad cholesterol, thereby enhancing the body’s ability to eliminate it more efficiently.
Increased levels of bad cholesterol in the bloodstream can result in hypercholesterolemia, a condition that harms arteries and increases the likelihood of heart disease.
As a result, this new treatment has the potential to reduce bad cholesterol by nearly 50%, which could provide significant relief for healthcare professionals.
New treatment for cholesterol
Researchers from the University of Barcelona and the University of Oregon have created a promising new strategy for managing cholesterol levels, presenting a potential new method to address atherosclerosis, a condition characterised by the accumulation of fatty plaques in arterial walls.
They have engineered tiny DNA-based molecules that inhibit PCSK9, a vital protein that maintains the circulation of “bad” LDL cholesterol in the bloodstream.
By obstructing this protein, cells are able to absorb more cholesterol rather than allowing it to accumulate in arteries, resulting in a dramatic decrease in levels associated with heart disease.
Read more: Health alert on Congo virus before Eid ul Adha 2026
